APOBEC3B and AID have similar nuclear import mechanisms.
暂无分享,去创建一个
[1] T. Eggerman,et al. Hypermutation of ApoB mRNA by rat APOBEC-1 overexpression mimics APOBEC-3 hypermutation. , 2012, Journal of molecular biology.
[2] Vasco M. Barreto,et al. Activation-induced cytidine deaminase structure and functions: a species comparative view. , 2011, Developmental and comparative immunology.
[3] J. V. Moran,et al. Endogenous APOBEC3B Restricts LINE-1 Retrotransposition in Transformed Cells and Human Embryonic Stem Cells* , 2011, The Journal of Biological Chemistry.
[4] Lela Lackey,et al. Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity To Restrict Vif-Deficient HIV-1 , 2011, Journal of Virology.
[5] V. Pathak,et al. The Role of Amino-Terminal Sequences in Cellular Localization and Antiviral Activity of APOBEC3B , 2011, Journal of Virology.
[6] Ming Li,et al. Phosphorylation Directly Regulates the Intrinsic DNA Cytidine Deaminase Activity of Activation-induced Deaminase and APOBEC3G Protein* , 2011, The Journal of Biological Chemistry.
[7] J. Weill,et al. AID and partners: for better and (not) for worse. , 2011, Current opinion in immunology.
[8] Anne E Carpenter,et al. Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software , 2011, Bioinform..
[9] M. Neuberger,et al. CTNNBL1 Is a Novel Nuclear Localization Sequence-binding Protein That Recognizes RNA-splicing Factors CDC5L and Prp31 , 2011, The Journal of Biological Chemistry.
[10] A. Chicca,et al. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function. , 2011, Molecular biology and evolution.
[11] Brigitte L. Arduini,et al. APOBEC2, a selective inhibitor of TGFβ signaling, regulates left-right axis specification during early embryogenesis. , 2011, Developmental biology.
[12] Marco Biasini,et al. Toward the estimation of the absolute quality of individual protein structure models , 2010, Bioinform..
[13] W. Greene,et al. HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors. , 2010, Molecular aspects of medicine.
[14] N. Davidson,et al. APOBEC‐1‐mediated RNA editing , 2010, Wiley interdisciplinary reviews. Systems biology and medicine.
[15] Kefei Yu,et al. Cutting Edge: CTNNBL1 Is Dispensable for Ig Class Switch Recombination , 2010, The Journal of Immunology.
[16] M. Goodman,et al. GANP-mediated Recruitment of Activation-induced Cytidine Deaminase to Cell Nuclei and to Immunoglobulin Variable Region DNA* , 2010, The Journal of Biological Chemistry.
[17] C. Schiffer,et al. Crystal structure of the APOBEC3G catalytic domain , 2010 .
[18] Steffen Frey,et al. Characterisation of the passive permeability barrier of nuclear pore complexes , 2009, The EMBO journal.
[19] N. Landau,et al. Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent. , 2009, Virology.
[20] Alexandre Orthwein,et al. Active nuclear import and cytoplasmic retention of activation-induced deaminase , 2009, Nature Structural &Molecular Biology.
[21] C. Woodward,et al. Integrase Interacts with Nucleoporin NUP153 To Mediate the Nuclear Import of Human Immunodeficiency Virus Type 1 , 2009, Journal of Virology.
[22] D. Schatz,et al. Balancing AID and DNA repair during somatic hypermutation. , 2009, Trends in immunology.
[23] R. Harris,et al. AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity , 2009, Nucleic acids research.
[24] Timothy P. L. Smith,et al. The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals , 2008, BMC Molecular Biology.
[25] S. O’Brien,et al. Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins , 2008, Journal of Virology.
[26] M. Neuberger,et al. Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1. , 2008, Molecular cell.
[27] H. Matsuo,et al. Two Regions within the Amino-Terminal Half of APOBEC3G Cooperate To Determine Cytoplasmic Localization , 2008, Journal of Virology.
[28] S. Conticello. The AID/APOBEC family of nucleic acid mutators , 2008, Genome Biology.
[29] J. Weill,et al. Proteasomal degradation restricts the nuclear lifespan of AID , 2008 .
[30] R. Harris,et al. The DNA Deaminase Activity of Human APOBEC3G Is Required for Ty1, MusD, and Human Immunodeficiency Virus Type 1 Restriction , 2008, Journal of Virology.
[31] M. Marin,et al. Human Immunodeficiency Virus Type 1 Vif Functionally Interacts with Diverse APOBEC3 Cytidine Deaminases and Moves with Them between Cytoplasmic Sites of mRNA Metabolism , 2007, Journal of Virology.
[32] B. Cullen,et al. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains. , 2007, Virology.
[33] Wei Zhang,et al. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression , 2007, Cellular microbiology.
[34] M. Neuberger,et al. Molecular mechanisms of antibody somatic hypermutation. , 2007, Annual review of biochemistry.
[35] M. Shimura,et al. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition , 2007, Nucleic acids research.
[36] E. Eichler,et al. Population Stratification of a Common APOBEC Gene Deletion Polymorphism , 2007, PLoS genetics.
[37] Anne E Carpenter,et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.
[38] D. Schatz,et al. AID and Igh switch region-Myc chromosomal translocations. , 2006, DNA repair.
[39] J. Löwer,et al. APOBEC3 Proteins Inhibit Human LINE-1 Retrotransposition* , 2006, Journal of Biological Chemistry.
[40] J. Wedekind,et al. Structural Phylogenetic Analysis of Activation-Induced Deaminase Function12 , 2006, The Journal of Immunology.
[41] M. Stenglein,et al. APOBEC3B and APOBEC3F Inhibit L1 Retrotransposition by a DNA Deamination-independent Mechanism* , 2006, Journal of Biological Chemistry.
[42] J. V. Moran,et al. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[43] S. Wain-Hobson,et al. Interferon‐inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication , 2006, Hepatology.
[44] Donna A. MacDuff,et al. Directed DNA deamination by AID/APOBEC3 in immunity , 2006, Current Biology.
[45] C. Lilley,et al. APOBEC3A Is a Potent Inhibitor of Adeno-Associated Virus and Retrotransposons , 2006, Current Biology.
[46] K. Marcu,et al. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system. , 2006, Molecular immunology.
[47] Torsten Schwede,et al. BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .
[48] B. Cullen,et al. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells , 2006, Nucleic acids research.
[49] E. Koonin,et al. APOBEC4, a New Member of the AID/APOBEC Family of Polynucleotide (Deoxy)Cytidine Deaminases Predicted by Computational Analysis , 2005, Cell cycle.
[50] A. Fischer,et al. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2. , 2005, Clinical immunology.
[51] B. Paschal,et al. Mechanisms of Receptor‐Mediated Nuclear Import and Nuclear Export , 2005, Traffic.
[52] M. Neuberger,et al. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. , 2005, Molecular biology and evolution.
[53] Reuben S. Harris,et al. Retroviral restriction by APOBEC proteins , 2004, Nature Reviews Immunology.
[54] D. Goldfarb,et al. Importin α: A multipurpose nuclear-transport receptor , 2004 .
[55] M. Malim,et al. Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins , 2004, Current Biology.
[56] M. Watson,et al. Activation-induced Cytosine Deaminase (AID) Is Actively Exported out of the Nucleus but Retained by the Induction of DNA Breaks* , 2004, Journal of Biological Chemistry.
[57] Takeshi Kurosu,et al. Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication , 2004, Journal of Virology.
[58] Vasco M. Barreto,et al. Somatic Hypermutation Is Limited by CRM1-dependent Nuclear Export of Activation-induced Deaminase , 2004, The Journal of experimental medicine.
[59] Reiko Shinkura,et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1 , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[60] S. Kennedy,et al. A Novel Nuclear Localization Signal in the Auxiliary Domain of Apobec-1 Complementation Factor Regulates Nucleocytoplasmic Import and Shuttling* , 2003, Journal of Biological Chemistry.
[61] T. Honjo,et al. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[62] J. Gasiorowski,et al. Mechanisms of nuclear transport and interventions. , 2003, Advanced drug delivery reviews.
[63] Y. Yang,et al. Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein B mRNA. , 2001, Experimental cell research.
[64] K Ribbeck,et al. Kinetic analysis of translocation through nuclear pore complexes , 2001, The EMBO journal.
[65] A. Fischer,et al. Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2) , 2000, Cell.
[66] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[67] L. Chan,et al. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family. , 1999, Biochemical and biophysical research communications.
[68] Y. Yang,et al. Multiple protein domains determine the cell type-specific nuclear distribution of the catalytic subunit required for apolipoprotein B mRNA editing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[69] F. Bischoff,et al. Dominant‐negative mutants of importin‐β block multiple pathways of import and export through the nuclear pore complex , 1997, The EMBO journal.
[70] Subhas Banerjee,et al. Apobec-1 Interacts with a 65-kDa Complementing Protein to Edit Apolipoprotein-B mRNA in Vitro * , 1996, The Journal of Biological Chemistry.
[71] J. Morrison,et al. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. , 1993, The Journal of biological chemistry.
[72] C. Burant,et al. Molecular cloning of an apolipoprotein B messenger RNA editing protein. , 1993, Science.
[73] S. Adam,et al. Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors , 1990, The Journal of cell biology.
[74] Sabyasachi Das,et al. The evolution of adaptive immunity in vertebrates. , 2011, Advances in immunology.
[75] T. Schwede,et al. Protein structure homology modeling using SWISS-MODEL workspace , 2008, Nature Protocols.
[76] L. Pasqualucci,et al. AID is required for germinal center–derived lymphomagenesis , 2008, Nature Genetics.
[77] F. Papavasiliou,et al. Beyond SHM and CSR: AID and related cytidine deaminases in the host response to viral infection. , 2007, Advances in immunology.
[78] T. Honjo,et al. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID. , 2006, International immunology.
[79] A. Fischer,et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. , 2004, Clinical immunology.
[80] U. Kutay,et al. Transport between the cell nucleus and the cytoplasm. , 1999, Annual review of cell and developmental biology.
[81] Y. Wang,et al. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. , 1997, Chemistry & biology.